Activity of anchored human matrix metalloproteinase-1 catalytic domain on Au (111) surfaces monitored by ESI-MS

Journal of Mass Spectrometry

Volumn 40, Issue 12, 2005, Pages 1565-1571

  Grasso, Giuseppe ^a   D'Agata, Roberta ^b   Rizzarelli, Enrico ^b,c   Spoto, Giuseppe ^b,c   D'Andrea, Luca ^c   Pedone, Carlo ^c   Picardi, Andrea ^c   Romanelli, Alessandra ^d   Fragai, Marco ^e   Yeo, Kwon Joo ^e  

^a Consorzio Interuniversitario di Ricerca in Chimica dei Metalli Nei Sistemi Biologici ^*  (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Activity assay; ESI MS; Human fibroblast collagenase; Matrix metalloproteinases; SPR

Indexed keywords

BIOTECHNOLOGY; CATALYSIS; FOURIER TRANSFORMS; GOLD; MASS SPECTROMETRY; SURFACE PHENOMENA;

ACTIVITY ASAY; ESI-MS; HUMAN FIBROBLAST COLLAGENASE; MATRIX METYALLOPROTEINASE; SPR;

ENZYMES;

GOLD; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; ZINC;

CANCER; CATALYSIS; CONFERENCE PAPER; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; EXTRACELLULAR MATRIX; FIBROSIS; FOURIER TRANSFORMATION; LUNG EMPHYSEMA; MOLECULAR WEIGHT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURFACE PLASMON RESONANCE;

EID: 30044445496     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.929     Document Type: Article

References (43)

1. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 1998; 12: 1075.
2. Christopher M. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 2002; 22: 51.
3. Nagase H, Woessner JF. Matrix metalloproteinases. J. Biol. Chem. 1999; 274: 21491.
4. Pardo A, Selman M. MMP-1: the elder of the family. Int. J. Biochem. Cell Biol. 2005; 37: 283.
5. Bauer EA, Eisen AZ, Jeffrey JJ. Immunologic relationship of a purified human skin collagenase to other human and animal collagenases. Biochim. Biophys. Acta 1970; 206: 152.
6. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 1986; 261: 6600.
7. Lovejoy B, Hassell AM, Luther MA, Weigl D, Jordan SR. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. Biochemistry 1994; 33: 8207.
8. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem. Biol. 1996; 3: 895.
9. Liu Z, Zhou XY, Shapiro SD, Shipley JM, Twining SS, Diaz LA. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 2000; 102: 647.
10. Farkas E, Katz Y, Bhusare S, Reich R, Röschenthaler G, Königsmann M, Breuer E. Carbamoylphosphonate based matrix metalloproteinase (MMP) inhibitor metal complexes - solution studies and stability constants. Towards a Zinc Selective Binding Group. J. Biol. Inorg. Chem. 2004; 9: 307.
11. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkilä P, Kantor C, Gahmbergl CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 1999; 17: 768.
12. Dive V, Andarawewa KL, Boulay A, Matziari M, Beau F, Guerin E, Rousseau B, Yiotakis A, Rio M. Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases. Int. J. Cancer 2005; 113: 775.
13. Xia T, Akers K, Eisen AZ, Seltzer JL. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides. Biochim. Biophys. Acta 1996; 1293: 259.
14. Weingarten H, Feder J. Spectrophotometric assay for vertebrate collagenase. Anal. Biochem. 1985; 147: 437.
15. Beekman B, Drijfhout JW, Bloemhoff W, Ronday HK, Tak PP, te Koppele JM. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett. 1996; 390: 221.
16. Liu Y, Kati W, Chen C, Tripathy R, Molla A, Kohlbreuner W. Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction. Anal. Biochem. 1999; 267: 331.
17. Babiak P, Reymond J. A high-throughput, low-volume enzyme assay on solid support. Anal. Chem. 2005; 77: 373.
18. Min D, Mrksich M. Profiling kinase activities by using a peptide chip and mass spectrometry. Angew. Chem. Int. Ed. Engl. 2004; 43: 5973.
19. Houseman BT, Huk JH, Kron SJ, Mrksich M. Peptide chips for the quantitative evaluation of protein kinase activity. Nat. Biotechnol. 2002; 20: 270.
20. Huber A, Demartis S, Neri D. The use of biosensor technology for the engineering of antibodies and enzymes. J. Mol. Recognit. 1999; 12: 198.
21. Lauer-Fields JL, Nagase H, Fields GB. Development of a solid-phase assay for analysis of matrix metalloproteinase activity. J. Biomol. Tech. 2004; 15: 305.
22. Nedelkov D, Nelson RW. Analysis of native proteins from biological fluids by biomolecular interaction analysis mass spectrometry (BIA/MS): exploring the limit of detection, identification of non-specific binding and detection of multi-protein complexes. Biosens. Bioelectron. 2001; 16: 1071.
23. Nedelkov D, Nelson RW. Pratical considerations in BIA/MS: optimizing the biosensor-mass spectrometry interface. J. Mol. Recognit. 2000; 13: 140.
24. Borch J, Roepstorff P. Screening for enzyme inhibitors by surface plasmon resonance combined with mass spectrometry. Anal. Chem. 2004; 76: 5243.
25. Olson MW, Gervasi DC, Mobashery S, Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 1997; 272: 29975.
26. Pieper-Fürst U, Kleuser U, Stöcklein WFM, Warsinke A, Scheller FW. Detection of subpicomolar concentrations of human matrix metalloproteinase-2 by an optical biosensor. Anal. Biochem. 2004; 332: 160.
27. Johnsson B, Löfas S, Lindquist G. Immobilization of proteins to a carboxy methyldextran-modified gold surface for biospecific interaction analysis insurface plasmon resonance sensors. Anal. Biochem. 1991; 198: 268.
28. Dordi B, Schönherr H, Vancso GJ. Reactivity in the confinement of self-assembled monolayers: chain length effects on the hydrolysis of N-hydroxysuccinimide ester disulfides on gold. Langmuir 2003; 19: 5780.
29. Weingarten H, Martin R, Feder J. Synthetic substrates of vertebrate collagenase. Biochemistry 1985; 24: 6730.
30. MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhu L, Hu S, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT. Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J. Med. Chem. 1997; 40: 2525.
31. Lide DR. Handbook of Chemistry and Physics, 71st ed., CRC Press: Boston, 1990.
32. Jung LS, Campbell CT, Chinowsky TM, Mar MN, Yee SS. Quantitative interpretation of the response of surface plasmon resonance sensors to adsorbed films. Langmuir 1998; 14: 5636.
33. Armstrong SH, Budkak MJE, Morrison C, Hasson M. Preparation and properties of serum and plasma proteins. XII. The refractive properties of the proteins of human plasma and certain purified fraction. J. Am. Chem. Soc. 1947; 69: 1747.
34. Darnell JE, Lodish H, Baltimore D. Molecular Cell Biology. Scientific American Books: New York, 1990.
35. Leslie TE, Lilley TH. Aqueous solutions containing amino acids and peptides. Part 20. Volumetric behavior of some terminally substituted amino acids and peptides at 298.15 K. Biopolymers 1985; 24: 695.
36. Wang X, Sakuma T, Asafu-Adjaye E, Shiu GK. Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. By LC/MS/MS. Anal. Chem. 1999; 71: 1579.
37. Mauri P, Migliazza B, Pietta P. Liquid chromatography/electrospray mass spectrometry of bioactive terpenoids in Ginkgo biloba L. J. Mass Spectrom. 1999; 34: 1361.
38. Iavarone AT, Udekwu OA, Williams ER. Buffer loading for counteracting metal salt-induced signal suppression in electrospray ionization. Anal. Chem. 2004; 76: 3944.
39. Clark IM, Mitchell RE, Powell LK, Bigg HF, Cawston TE, O'Hare MC. Recombinant porcine collagenase: purification and autolysis. Arch. Biochem. Biophys. 1995; 316: 123.
40. 2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme. Anal. Biochem. 2004; 328: 166.
41. Pi N, Armstrong JI, Bertozzi CR, Leary JA. Kinetic analysis of NodST sulfotransferase using an electrospray ionization mass spectrometry assay. Biochemistry 2002; 41: 13283.
42. Nagase H, Fields CG, Fields GB. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J. Biol. Chem. 1994; 269: 20952.
43. 2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme. Anal. Biochem. 2004; 328: 166.